Inogen, inc. reports inducement grants under nasdaq listing rule 5635(c)(4)

Goleta, calif.--(business wire)--inogen, inc. (nasdaq: ingn), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective march 4, 2024, the compensation committee of inogen's board of directors approved awards of restricted stock units as material inducement to michael bourque entering into employment with the company to serve as its executive vice president, chief financial officer and treasurer. the equity awards were.
INGN Ratings Summary
INGN Quant Ranking